In vitro experiments have revealed that ubiquitin carboxy-terminal hydrolase isozyme L5 could inhibit human glioma cell migration and invasion by downregulating SNRPF (Ge et al., 2017). The gene discussed is SNRPF; the disease is central nervous system cancer.